Login

Exploring Global Ventures: An Interview with Marco Soriano, CEO of Soriano Group 00:10:00

Share On Facebook Share On Twitter

Marco Antonio SORIANO VII, CEO of The Soriano Group and its global subsidiaries

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Business of Venture Capital|Lauren Kolodny, Managing Partner at Acrew Capital
00:10:00
Streamlining ICT: Dai Nippon Printing & DNP Information Systems Case Study
00:10:00
Dundee's Arsenic Stabilization: Converting Toxic Waste into Safe, Long-Lasting Glass
00:10:00
Monte Carlo Rendezvous: Tim Gardner on Market Trends and Risk Appetite in Insurance
00:10:00
Frontier Diamonds: South African Mines Expansion and Innovative Diamond Recovery
00:10:00
FESA4 Investment Analysis: Historical Overview & Financial Evaluation | Silvano Andrade - CEO of Companhia de Ferro Ligas da Bahia - FERBASA
00:10:00
How to Recover Funds from Pox Group Scams with MFG Inc.
00:10:00
A venture we back offers one or more of the factors:Significant technology or business model innovation|Peter Buckland,General Partner and COO,Khosla Ventures
00:10:00
What is a CEO's day like? CEO X from Lassila & Tikanoja Oyj was live on June 13, 2017.
00:10:00
Milbank@Harvard Professional Development Program
00:10:00
Gold Expansion Prospects: Garden Rooms' Maiden Resource and Future Drilling Plans at One-to-One Conference in London
00:10:00
Joymode is enabling rental commerce for the good of consumers and the planet|Al Sambar,General Partner,XRC Labs

© 2026 Nehu